Tag: mood disorder

Section 5: Psychedelic use in the long-term Serious adverse reactions have not been a recognized risk through ongoing research, though some are concerned about long-term use and the time at which psychedelic drug treatment should be considered. Psychotic disorders, when they occur in a very small group of people, they...
Section 1: Psychedelics as a potential therapeutic option for psychiatric conditions Psychedelic drugs, such as lysergic acid diethylamide (LSD), was of interest to molecular psychiatry in the 1950s due to its considerable chemical similarity to serotonin (5-HT). In the context of a highly regulated system, the use of psychedelics in...
1. Concomitant antidepressant and benzodiazepine therapy was associated with an increased risk of all-cause mortality over antidepressant monotherapy in patients with depression. Evidence Rating Level: 2 (Good) As antidepressants (ADs) may take several weeks to show therapeutic effect, benzodiazepines (BZDs) are often prescribed concomitantly to manage anxiety or insomnia in patients...
1. Mood homeostasis, or the preferential ability to engage in adequate mood-modifying behaviors, is associated with mean mood and history of depression. 2. Individuals with low mean mood had significantly lower mood homeostasis scores than those with higher mean moods. This relationship was also found among those who had a...
Childhood-onset inflammatory bowel disease (IBD) typically has a more severe course than adult-onset IBD, and has been found to be associated with psychiatric morbidity in previous studies. However, these studies have failed to account for familial confounding. In this population-based cohort study, 6,464 patients with childhood-onset IBD were compared...